A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to compare the safety, tolerability, and mean change
from baseline in diurnal intraocular pressure (IOP) of ONO-9054 30 µg/mL (0.003%) to
latanoprost 0.005% following ocular instillation once every evening for 28 days.